Navigation Links
PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
Date:6/24/2008

view the accompanying slides should log onto the Company's website at http://www.parexel.com and click on the PAREXEL International Investor Day link under the "Upcoming Events" section of the Investors homepage at least 15 minutes prior to the event's broadcast which will start at 8:30 a.m. EDT. Users should follow the instructions provided to assure that the necessary audio applications are downloaded and installed. In addition, an archived version of the event's presentations will be located in the Investor Relations section of PAREXEL's website.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 63 locations throughout 52 countries around the world, and has over 7,680 employees. For more information about PAREXEL International visit http://www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events, including, without limitation, statements regarding expected financial results, future growth and customer demand, such as the guidance provided by the Company with respect to the fourth quarter of Fiscal Y
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. PAREXEL International Announces 2-For-1 Stock Split

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...and,November24/PRNewswire-FirstCall/--deCODE,genet...allofits,"firstday"motionsbytheU.S.BankruptcyCourt...CODElastweekfiledavoluntarypetitionfor,reliefunder...nkruptcyCourt. , TheordersissuedbytheBankrupt...essduringtheChapter11proceedings.Inparticular,the,...
(Date:11/24/2009)...4/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Ch...ovedthe,investigationalnewdrugapplication(IND)fori...ormulationtotreatdiabetes.ThisIND,approvalallowsBi... Diabetesisadisordercharacteristicofhighbloodgluco...enresultinseveremicro-and,macro-vasculardiseases,l...
(Date:11/24/2009)...yendpointhasbeenmetforpatientswithadvanced-stage,o....24/PRNewswire-FirstCall/-AEternaZentarisInc.(NASD...euticalcompanyfocusedonendocrinetherapyandoncology...ywithitstargetedcytotoxicpeptideconjugate,AEZS-108...endometrialcancer.Inapersonalizedhealthcareapproac...
(Date:11/24/2009)...4,2009/PRNewswire-FirstCall/--ArenaPharmaceuticals...isscheduledtopresentatthePiperJaffray21stAnnualHea...nTime(8:30a.m.PacificTime)attheNewYorkPalaceHoteli...ecutiveOfficer,isscheduledtoprovideanoverviewofthe...yprograms. ,, Aliveaudiowebcastofthepresentatio...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...c. 19 Interleukin Genetics,Inc. (Amex: ILI ) ann...iary,Pyxis Innovations Inc., has converted a total...s common stock. The converted debt represents,prin...ssued from October,2002 through January 2003 which...rms of the Promissory Notes, the conversion price ...
...c. 19 A free white paper to help,biotechnology te...S),personnel minimize the risk of infection in the...www.eheinc.com/biosafety.htm ., Exposure to infec...,health hazards to staff during many routine cell ...y and pharmaceutical laboratories. This,along with...
...s Accurate Marketing Claims Designed with Input fr...tion,s leading livestock,cloning companies announc...anagement system that will allow food companies to...ood processing chain., The program was developed ... last year with all critical participants in the f...
Other Biology Technology:Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock 2Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock 3Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control 2Top U.S. Cloning Companies Announce New System to Track Cloned Livestock 2
(Date:11/23/2009)...DISON, WI, November 16, 2009 -- A USDOE and USDA s...and, idle cropland, and cropland pasture could be ...erennial grasses, such as switchgrass, from which ...edstock. Economically viable production of a peren...tities of biomass are removed annually is expected...
(Date:11/23/2009)...University of Southern California biomedical engin...evelop a new tool to help clinicians distinguish c...m chronic problems manageable with drugs and lifes...ers inserted into the arteries feeding the heart, ...en") of these blood vessels, often revealing depos...
(Date:11/23/2009)...e National Institute of General Medical Sciences (...(NIH), is investing $42.3 million for grants in sc...es (GO)." NIH developed the GO grant program to st...funds provided by the American Recovery and Reinve... projects that promise to have a significant impac...
Breaking Biology News(10 mins):Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Not Getting Enough Fruits and Vegetables 3F Think Frozen 21 Antioxidant rich Frozen Wild Blueberries are Convenient and Just As Nutritious As Fresh 59567 1Not Getting Enough Fruits and Vegetables 3F Think Frozen 21 Antioxidant rich Frozen Wild Blueberries are Convenient and Just As Nutritious As Fresh 59567 2MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 1MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 2MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology 14494 3comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions 5518 1comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions 5518 2comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions 5518 3comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions 5518 4comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions 5518 5
...lion-year-old dino tracks may be to hang out with ...nosaur footprints at the Red Gulch Dinosaur Tracks...e same size, walk on two legs and have similar fee...the enigmatic reptiles that once trotted along a l...on,t have any documented dinosaur bones and teeth ...
...California, San Diego and Yale University have dis...s thuringiensis, a bacterium sprayed on crops by o...effective at treating hookworm infections in labor...is week,s early online edition of the Proceedings ...e way for the development of more effective treatm...
...he gene that controls the colour of apples ?a disc... , "The red colour in apple skin is the result of ...ble for blue and red colours in many flowers and f...y research team, Dr Mandy Walker. , "Colour is a.... "If fruit doesn,t look good, consumers are far l...
Other Biology News:Trotting with emus to walk with dinosaurs 2Trotting with emus to walk with dinosaurs 3Bacterial protein shows promise in treating intestinal parasites 2Bacterial protein shows promise in treating intestinal parasites 3Found -- the apple gene for red 2
BD FACSAria Cell Sorting System from BD Biosciences - Immunocytometry Systems
EGTA from Research Organics, Inc.
...minescence efficiencies and the chemistry of light...d benefit that they require simple triggering cond...gnal. This benefit has been exploited to great eff...These compounds can also be easily modified to att...
GSD-501 System Calibration Kit from Invitrogen
Biology Products: